An evaluation of once-daily applications of diflorasone diacetate in eczematous dermatoses.
The efficacy of once-daily applications of 0.05% diflorasone diacetate in a cream or ointment formulation was evaluated in a 3-week study of 301 patients with eczematous dermatoses. The lesions were classified by severity and included those of an acute, sub-acute or chronic nature. Clinical evaluations were based on overall lesion improvement and improvement in specific signs and symptoms. Over 80% of patients reported the therapy to be good or excellent. Sixteen patients reported side-effects consisting largely of transient burning and stinging.